

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.39893441 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.04101035 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.74149142 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.71033201 |
| 5 | vocalization behavior (GO:0071625) | 5.65444287 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.65406069 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.53545037 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.52678726 |
| 9 | glutamate secretion (GO:0014047) | 5.17155104 |
| 10 | protein localization to synapse (GO:0035418) | 5.13842707 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.10879476 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.08424113 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.92434642 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.72233200 |
| 15 | exploration behavior (GO:0035640) | 4.66760252 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 4.64462228 |
| 17 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.58560447 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.54896964 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.49225344 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.45125387 |
| 21 | regulation of synapse structural plasticity (GO:0051823) | 4.39521383 |
| 22 | layer formation in cerebral cortex (GO:0021819) | 4.34991472 |
| 23 | neuronal action potential propagation (GO:0019227) | 4.32297431 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 4.27810997 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 4.23423384 |
| 26 | dendritic spine morphogenesis (GO:0060997) | 4.22728765 |
| 27 | synaptic vesicle endocytosis (GO:0048488) | 4.18176630 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.15489104 |
| 29 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.05029798 |
| 30 | neuron-neuron synaptic transmission (GO:0007270) | 4.04438690 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.03374034 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 3.93903712 |
| 33 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.91116265 |
| 34 | long-term memory (GO:0007616) | 3.88678296 |
| 35 | proline transport (GO:0015824) | 3.86522350 |
| 36 | gamma-aminobutyric acid transport (GO:0015812) | 3.82092528 |
| 37 | positive regulation of membrane potential (GO:0045838) | 3.81325799 |
| 38 | presynaptic membrane organization (GO:0097090) | 3.80952578 |
| 39 | cellular potassium ion homeostasis (GO:0030007) | 3.79830786 |
| 40 | presynaptic membrane assembly (GO:0097105) | 3.75824060 |
| 41 | neuron recognition (GO:0008038) | 3.75383310 |
| 42 | regulation of postsynaptic membrane potential (GO:0060078) | 3.74174045 |
| 43 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.70290962 |
| 44 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.69516616 |
| 45 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.68279609 |
| 46 | behavioral response to nicotine (GO:0035095) | 3.67681321 |
| 47 | nucleobase catabolic process (GO:0046113) | 3.66258542 |
| 48 | regulation of synaptic plasticity (GO:0048167) | 3.63030892 |
| 49 | neuromuscular process controlling posture (GO:0050884) | 3.62518604 |
| 50 | neurotransmitter transport (GO:0006836) | 3.60434272 |
| 51 | neuromuscular process controlling balance (GO:0050885) | 3.56802315 |
| 52 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.54018117 |
| 53 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.50939871 |
| 54 | neuromuscular synaptic transmission (GO:0007274) | 3.50517267 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.49980600 |
| 56 | transmission of nerve impulse (GO:0019226) | 3.49728459 |
| 57 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.49022831 |
| 58 | cell migration in hindbrain (GO:0021535) | 3.46567930 |
| 59 | sodium ion export (GO:0071436) | 3.45806543 |
| 60 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.45689908 |
| 61 | axonal fasciculation (GO:0007413) | 3.43049913 |
| 62 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.40133358 |
| 63 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.39969749 |
| 64 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.39742052 |
| 65 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.39293575 |
| 66 | activation of protein kinase A activity (GO:0034199) | 3.38775314 |
| 67 | long-term synaptic potentiation (GO:0060291) | 3.38217949 |
| 68 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.37618418 |
| 69 | positive regulation of dendritic spine development (GO:0060999) | 3.34648980 |
| 70 | postsynaptic membrane organization (GO:0001941) | 3.34544485 |
| 71 | regulation of vesicle fusion (GO:0031338) | 3.33908977 |
| 72 | regulation of neurotransmitter levels (GO:0001505) | 3.30284426 |
| 73 | response to pheromone (GO:0019236) | 3.28706920 |
| 74 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.27616667 |
| 75 | auditory behavior (GO:0031223) | 3.26435011 |
| 76 | dendrite morphogenesis (GO:0048813) | 3.24351623 |
| 77 | startle response (GO:0001964) | 3.23965738 |
| 78 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.23933208 |
| 79 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.23790407 |
| 80 | cell communication by electrical coupling (GO:0010644) | 3.22366135 |
| 81 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.21352026 |
| 82 | membrane depolarization (GO:0051899) | 3.21138055 |
| 83 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.21037235 |
| 84 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.21037235 |
| 85 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.21037134 |
| 86 | regulation of neurotransmitter transport (GO:0051588) | 3.20998540 |
| 87 | prepulse inhibition (GO:0060134) | 3.20991915 |
| 88 | behavioral fear response (GO:0001662) | 3.20531383 |
| 89 | behavioral defense response (GO:0002209) | 3.20531383 |
| 90 | establishment of mitochondrion localization (GO:0051654) | 3.18774133 |
| 91 | learning (GO:0007612) | 3.17652419 |
| 92 | response to auditory stimulus (GO:0010996) | 3.16728664 |
| 93 | membrane hyperpolarization (GO:0060081) | 3.16663101 |
| 94 | innervation (GO:0060384) | 3.16400069 |
| 95 | positive regulation of neurotransmitter transport (GO:0051590) | 3.16370122 |
| 96 | membrane depolarization during action potential (GO:0086010) | 3.14320678 |
| 97 | dendritic spine organization (GO:0097061) | 3.13415138 |
| 98 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.13231372 |
| 99 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.13043455 |
| 100 | glycine transport (GO:0015816) | 3.12184424 |
| 101 | regulation of dendritic spine development (GO:0060998) | 3.10266410 |
| 102 | cerebellar granule cell differentiation (GO:0021707) | 3.09259480 |
| 103 | neurofilament cytoskeleton organization (GO:0060052) | 3.09039366 |
| 104 | neuromuscular process (GO:0050905) | 3.08964064 |
| 105 | serotonin metabolic process (GO:0042428) | 3.07146322 |
| 106 | axon ensheathment in central nervous system (GO:0032291) | 3.06870998 |
| 107 | central nervous system myelination (GO:0022010) | 3.06870998 |
| 108 | response to histamine (GO:0034776) | 3.06372426 |
| 109 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.05324408 |
| 110 | regulation of synapse maturation (GO:0090128) | 3.03995421 |
| 111 | synapse assembly (GO:0007416) | 3.03529048 |
| 112 | regulation of synaptic transmission (GO:0050804) | 3.03079544 |
| 113 | neuronal ion channel clustering (GO:0045161) | 3.02514487 |
| 114 | fear response (GO:0042596) | 3.00604126 |
| 115 | synaptic transmission (GO:0007268) | 3.00541782 |
| 116 | positive regulation of synaptic transmission (GO:0050806) | 2.99553230 |
| 117 | intraspecies interaction between organisms (GO:0051703) | 2.98360509 |
| 118 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.97501722 |
| 119 | primary amino compound metabolic process (GO:1901160) | 2.95521271 |
| 120 | mechanosensory behavior (GO:0007638) | 2.92966283 |
| 121 | behavioral response to cocaine (GO:0048148) | 2.91604294 |
| 122 | potassium ion homeostasis (GO:0055075) | 2.88859252 |
| 123 | calcium ion-dependent exocytosis (GO:0017156) | 2.87634776 |
| 124 | adult walking behavior (GO:0007628) | 2.86451756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.12866078 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.28848710 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.16459766 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.11328589 |
| 5 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.07604680 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02888729 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.82973043 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.79152940 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.76553039 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.76553039 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.63791335 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.57128914 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55822250 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54813177 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53604796 |
| 16 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.53057882 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49934673 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46571693 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.43428126 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.36024704 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.33719952 |
| 22 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.29953030 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.27287305 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.26162542 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.25590465 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.23389234 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.04146016 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.01351826 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.92090678 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81951273 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76657315 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65371578 |
| 33 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.60574264 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.58029659 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54530835 |
| 36 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.46678266 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43936479 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42346364 |
| 39 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39592723 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38719421 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38512083 |
| 42 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.38193484 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37629393 |
| 44 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.32916564 |
| 45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.32692584 |
| 46 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32164097 |
| 47 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.26974792 |
| 48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26402529 |
| 49 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.25471628 |
| 50 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24686049 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22927472 |
| 52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21341591 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21210090 |
| 54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21133827 |
| 55 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18691742 |
| 56 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18313824 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.18187365 |
| 58 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17140957 |
| 59 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17086145 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13734187 |
| 61 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13209792 |
| 62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11387185 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11210776 |
| 64 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10733224 |
| 65 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09616584 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09479035 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09408375 |
| 68 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08642963 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08594361 |
| 70 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.07864157 |
| 71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07254473 |
| 72 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.05696795 |
| 73 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05656214 |
| 74 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05116211 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03172997 |
| 76 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03084755 |
| 77 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.02905547 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02806312 |
| 79 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02568538 |
| 80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02475772 |
| 81 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02390902 |
| 82 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02308074 |
| 83 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01282849 |
| 84 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00483135 |
| 85 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00411978 |
| 86 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00053909 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98528544 |
| 88 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97915298 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97592094 |
| 90 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97592094 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95611679 |
| 92 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95427834 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95376202 |
| 94 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93957424 |
| 95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93793847 |
| 96 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93112986 |
| 97 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93000929 |
| 98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92223604 |
| 99 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92178415 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91867132 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91828749 |
| 102 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.91637052 |
| 103 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.91317445 |
| 104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90843363 |
| 105 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90073968 |
| 106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.89750618 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89713506 |
| 108 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89524086 |
| 109 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.89479729 |
| 110 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89376024 |
| 111 | JUN_21703547_ChIP-Seq_K562_Human | 0.88800985 |
| 112 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88748305 |
| 113 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88538166 |
| 114 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87788604 |
| 115 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86217736 |
| 116 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85688363 |
| 117 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.85122565 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84533890 |
| 119 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84454711 |
| 120 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83559751 |
| 121 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82684153 |
| 122 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81977026 |
| 123 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81436716 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80943533 |
| 125 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80591834 |
| 126 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.80227883 |
| 127 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80227883 |
| 128 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78687517 |
| 129 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.78014487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.61134791 |
| 2 | MP0003880_abnormal_central_pattern | 4.78122501 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.21347063 |
| 4 | MP0004270_analgesia | 3.57286511 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.50301874 |
| 6 | MP0009745_abnormal_behavioral_response | 3.38851226 |
| 7 | MP0002064_seizures | 3.16267261 |
| 8 | MP0009046_muscle_twitch | 3.09678184 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.95797732 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.90437751 |
| 11 | MP0002822_catalepsy | 2.88031823 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.82502123 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.55814844 |
| 14 | MP0002272_abnormal_nervous_system | 2.53463277 |
| 15 | MP0001486_abnormal_startle_reflex | 2.50455622 |
| 16 | MP0002736_abnormal_nociception_after | 2.26356843 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.19063994 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.15467198 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.11394647 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.09381068 |
| 21 | MP0001970_abnormal_pain_threshold | 2.07328334 |
| 22 | MP0000778_abnormal_nervous_system | 2.00408316 |
| 23 | MP0002184_abnormal_innervation | 1.96750831 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.93365502 |
| 25 | MP0004811_abnormal_neuron_physiology | 1.90353634 |
| 26 | MP0006276_abnormal_autonomic_nervous | 1.87247863 |
| 27 | MP0008569_lethality_at_weaning | 1.80493030 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.79303312 |
| 29 | MP0004858_abnormal_nervous_system | 1.77020431 |
| 30 | MP0003329_amyloid_beta_deposits | 1.73356187 |
| 31 | MP0004924_abnormal_behavior | 1.73052866 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.73052866 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.71089320 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.70730365 |
| 35 | MP0001984_abnormal_olfaction | 1.70348940 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.69885017 |
| 37 | MP0000955_abnormal_spinal_cord | 1.68558380 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.65068063 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.64850177 |
| 40 | MP0002882_abnormal_neuron_morphology | 1.52748980 |
| 41 | MP0001529_abnormal_vocalization | 1.49523128 |
| 42 | MP0001502_abnormal_circadian_rhythm | 1.48400035 |
| 43 | MP0003879_abnormal_hair_cell | 1.45706073 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.45677859 |
| 45 | MP0003121_genomic_imprinting | 1.43916313 |
| 46 | MP0004142_abnormal_muscle_tone | 1.40158669 |
| 47 | MP0003122_maternal_imprinting | 1.40036075 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.33684622 |
| 49 | MP0003787_abnormal_imprinting | 1.33267777 |
| 50 | MP0003633_abnormal_nervous_system | 1.29528381 |
| 51 | MP0004885_abnormal_endolymph | 1.28159663 |
| 52 | MP0003123_paternal_imprinting | 1.21796147 |
| 53 | MP0002152_abnormal_brain_morphology | 1.19584386 |
| 54 | MP0001905_abnormal_dopamine_level | 1.19010947 |
| 55 | MP0001485_abnormal_pinna_reflex | 1.17980750 |
| 56 | MP0002102_abnormal_ear_morphology | 1.16516104 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.16326021 |
| 58 | MP0003283_abnormal_digestive_organ | 1.13563948 |
| 59 | MP0004233_abnormal_muscle_weight | 1.13167156 |
| 60 | MP0003631_nervous_system_phenotype | 1.09357972 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.07687128 |
| 62 | MP0000751_myopathy | 1.07133335 |
| 63 | MP0004147_increased_porphyrin_level | 1.03072938 |
| 64 | MP0005499_abnormal_olfactory_system | 0.99929901 |
| 65 | MP0005394_taste/olfaction_phenotype | 0.99929901 |
| 66 | MP0002069_abnormal_eating/drinking_beha | 0.98294950 |
| 67 | MP0000569_abnormal_digit_pigmentation | 0.98120692 |
| 68 | MP0002229_neurodegeneration | 0.96700278 |
| 69 | MP0001188_hyperpigmentation | 0.96131184 |
| 70 | MP0008872_abnormal_physiological_respon | 0.93086151 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 0.92747135 |
| 72 | MP0010386_abnormal_urinary_bladder | 0.92667025 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 0.90508091 |
| 74 | MP0002752_abnormal_somatic_nervous | 0.86582676 |
| 75 | MP0003075_altered_response_to | 0.85135955 |
| 76 | MP0003634_abnormal_glial_cell | 0.84769023 |
| 77 | MP0000631_abnormal_neuroendocrine_gland | 0.84688077 |
| 78 | MP0008874_decreased_physiological_sensi | 0.83178546 |
| 79 | MP0004133_heterotaxia | 0.82312372 |
| 80 | MP0006292_abnormal_olfactory_placode | 0.79009976 |
| 81 | MP0003137_abnormal_impulse_conducting | 0.77603015 |
| 82 | MP0004043_abnormal_pH_regulation | 0.77088419 |
| 83 | MP0001963_abnormal_hearing_physiology | 0.75959410 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.74890269 |
| 85 | MP0000013_abnormal_adipose_tissue | 0.74470005 |
| 86 | MP0001177_atelectasis | 0.74326496 |
| 87 | MP0004742_abnormal_vestibular_system | 0.74151444 |
| 88 | MP0005535_abnormal_body_temperature | 0.74028581 |
| 89 | MP0002653_abnormal_ependyma_morphology | 0.72790358 |
| 90 | MP0002090_abnormal_vision | 0.72499796 |
| 91 | MP0005171_absent_coat_pigmentation | 0.72413705 |
| 92 | MP0004085_abnormal_heartbeat | 0.72080299 |
| 93 | MP0000026_abnormal_inner_ear | 0.71945203 |
| 94 | MP0003632_abnormal_nervous_system | 0.71253330 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.70946142 |
| 96 | MP0003861_abnormal_nervous_system | 0.70334325 |
| 97 | MP0000920_abnormal_myelination | 0.69368574 |
| 98 | MP0003195_calcinosis | 0.67407433 |
| 99 | MP0002928_abnormal_bile_duct | 0.67008217 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 0.66595580 |
| 101 | MP0000604_amyloidosis | 0.65887728 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.65761682 |
| 103 | MP0005187_abnormal_penis_morphology | 0.65399467 |
| 104 | MP0005253_abnormal_eye_physiology | 0.63524037 |
| 105 | MP0001943_abnormal_respiration | 0.61050026 |
| 106 | MP0010769_abnormal_survival | 0.58598459 |
| 107 | MP0005623_abnormal_meninges_morphology | 0.58494886 |
| 108 | MP0008995_early_reproductive_senescence | 0.57929925 |
| 109 | MP0001664_abnormal_digestion | 0.57602999 |
| 110 | MP0002234_abnormal_pharynx_morphology | 0.57319187 |
| 111 | MP0002837_dystrophic_cardiac_calcinosis | 0.56686064 |
| 112 | MP0010768_mortality/aging | 0.56147811 |
| 113 | MP0010770_preweaning_lethality | 0.56050747 |
| 114 | MP0002082_postnatal_lethality | 0.56050747 |
| 115 | MP0005167_abnormal_blood-brain_barrier | 0.54718585 |
| 116 | MP0005195_abnormal_posterior_eye | 0.54281290 |
| 117 | MP0003956_abnormal_body_size | 0.53935279 |
| 118 | MP0002751_abnormal_autonomic_nervous | 0.53525563 |
| 119 | MP0003690_abnormal_glial_cell | 0.51069853 |
| 120 | MP0004215_abnormal_myocardial_fiber | 0.49781268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.22041996 |
| 2 | Focal motor seizures (HP:0011153) | 7.13917026 |
| 3 | Focal seizures (HP:0007359) | 5.48526546 |
| 4 | Visual hallucinations (HP:0002367) | 5.42135659 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.94870496 |
| 6 | Febrile seizures (HP:0002373) | 4.70687428 |
| 7 | Atonic seizures (HP:0010819) | 4.65619538 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.31580851 |
| 9 | Absence seizures (HP:0002121) | 4.16979040 |
| 10 | Action tremor (HP:0002345) | 3.78935689 |
| 11 | Dialeptic seizures (HP:0011146) | 3.76419777 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.64923356 |
| 13 | Ankle clonus (HP:0011448) | 3.62028402 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.59779720 |
| 15 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.35702606 |
| 16 | Broad-based gait (HP:0002136) | 3.33586118 |
| 17 | Poor eye contact (HP:0000817) | 3.23095788 |
| 18 | Mutism (HP:0002300) | 3.22649067 |
| 19 | Abnormality of the lower motor neuron (HP:0002366) | 3.21963411 |
| 20 | Dysdiadochokinesis (HP:0002075) | 3.18336612 |
| 21 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.18136363 |
| 22 | Depression (HP:0000716) | 3.14347076 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.09598861 |
| 24 | Abnormal eating behavior (HP:0100738) | 3.03772674 |
| 25 | Amblyopia (HP:0000646) | 2.97380180 |
| 26 | Impaired social interactions (HP:0000735) | 2.92692227 |
| 27 | Abnormal social behavior (HP:0012433) | 2.92692227 |
| 28 | Dysmetria (HP:0001310) | 2.89915377 |
| 29 | Truncal ataxia (HP:0002078) | 2.89110589 |
| 30 | Anxiety (HP:0000739) | 2.87988963 |
| 31 | Annular pancreas (HP:0001734) | 2.83926772 |
| 32 | Postural instability (HP:0002172) | 2.77785536 |
| 33 | Hemiparesis (HP:0001269) | 2.75191756 |
| 34 | Genetic anticipation (HP:0003743) | 2.72452859 |
| 35 | Urinary urgency (HP:0000012) | 2.66767511 |
| 36 | Excessive salivation (HP:0003781) | 2.63886853 |
| 37 | Drooling (HP:0002307) | 2.63886853 |
| 38 | Papilledema (HP:0001085) | 2.63373500 |
| 39 | Impaired smooth pursuit (HP:0007772) | 2.62478968 |
| 40 | Torticollis (HP:0000473) | 2.61243278 |
| 41 | Polyphagia (HP:0002591) | 2.60696245 |
| 42 | Spastic gait (HP:0002064) | 2.60082818 |
| 43 | Hyperventilation (HP:0002883) | 2.58933267 |
| 44 | Congenital stationary night blindness (HP:0007642) | 2.58720981 |
| 45 | Cerebral hypomyelination (HP:0006808) | 2.54764277 |
| 46 | Fetal akinesia sequence (HP:0001989) | 2.53206713 |
| 47 | Epileptiform EEG discharges (HP:0011182) | 2.47035711 |
| 48 | Focal dystonia (HP:0004373) | 2.44974087 |
| 49 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.41566131 |
| 50 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.41566131 |
| 51 | Limb dystonia (HP:0002451) | 2.40395776 |
| 52 | EEG with generalized epileptiform discharges (HP:0011198) | 2.37082135 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 2.37016408 |
| 54 | Bradykinesia (HP:0002067) | 2.36155867 |
| 55 | Intention tremor (HP:0002080) | 2.35363832 |
| 56 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.33988612 |
| 57 | Abnormality of binocular vision (HP:0011514) | 2.31195562 |
| 58 | Diplopia (HP:0000651) | 2.31195562 |
| 59 | Progressive inability to walk (HP:0002505) | 2.31095182 |
| 60 | Neurofibrillary tangles (HP:0002185) | 2.29949128 |
| 61 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.28940320 |
| 62 | Medial flaring of the eyebrow (HP:0010747) | 2.28329872 |
| 63 | Abnormality of midbrain morphology (HP:0002418) | 2.27772664 |
| 64 | Molar tooth sign on MRI (HP:0002419) | 2.27772664 |
| 65 | Ventricular fibrillation (HP:0001663) | 2.26854955 |
| 66 | Stereotypic behavior (HP:0000733) | 2.24614997 |
| 67 | Hemiplegia (HP:0002301) | 2.24257131 |
| 68 | Hypsarrhythmia (HP:0002521) | 2.23368518 |
| 69 | Failure to thrive in infancy (HP:0001531) | 2.22418333 |
| 70 | Scanning speech (HP:0002168) | 2.21507056 |
| 71 | Impaired vibratory sensation (HP:0002495) | 2.21390114 |
| 72 | Lower limb muscle weakness (HP:0007340) | 2.20597735 |
| 73 | Spastic tetraplegia (HP:0002510) | 2.20326371 |
| 74 | Lissencephaly (HP:0001339) | 2.19544078 |
| 75 | Craniofacial dystonia (HP:0012179) | 2.17907158 |
| 76 | Status epilepticus (HP:0002133) | 2.17883864 |
| 77 | Megalencephaly (HP:0001355) | 2.17383629 |
| 78 | Insidious onset (HP:0003587) | 2.17238348 |
| 79 | Termporal pattern (HP:0011008) | 2.17238348 |
| 80 | Gait imbalance (HP:0002141) | 2.15194106 |
| 81 | Abnormality of the corticospinal tract (HP:0002492) | 2.14746404 |
| 82 | Agitation (HP:0000713) | 2.14489627 |
| 83 | Pheochromocytoma (HP:0002666) | 2.13058014 |
| 84 | Dysmetric saccades (HP:0000641) | 2.12034385 |
| 85 | Amyotrophic lateral sclerosis (HP:0007354) | 2.10128783 |
| 86 | Pancreatic cysts (HP:0001737) | 2.09561433 |
| 87 | Nephrogenic diabetes insipidus (HP:0009806) | 2.09112903 |
| 88 | Absent speech (HP:0001344) | 2.08360397 |
| 89 | Specific learning disability (HP:0001328) | 2.07273117 |
| 90 | Type II lissencephaly (HP:0007260) | 2.04281665 |
| 91 | CNS hypomyelination (HP:0003429) | 2.03558876 |
| 92 | Muscular hypotonia of the trunk (HP:0008936) | 2.03006418 |
| 93 | True hermaphroditism (HP:0010459) | 2.02786754 |
| 94 | Incomplete penetrance (HP:0003829) | 2.01951070 |
| 95 | Clonus (HP:0002169) | 2.00661432 |
| 96 | Pointed chin (HP:0000307) | 1.99906459 |
| 97 | Nephronophthisis (HP:0000090) | 1.99737238 |
| 98 | Generalized myoclonic seizures (HP:0002123) | 1.99159233 |
| 99 | Abnormality of the labia minora (HP:0012880) | 1.98999227 |
| 100 | Pancreatic fibrosis (HP:0100732) | 1.98880423 |
| 101 | Insomnia (HP:0100785) | 1.98673703 |
| 102 | Retinal dysplasia (HP:0007973) | 1.98087629 |
| 103 | Obstructive sleep apnea (HP:0002870) | 1.96257195 |
| 104 | Delusions (HP:0000746) | 1.95918509 |
| 105 | Protruding tongue (HP:0010808) | 1.94383731 |
| 106 | Inability to walk (HP:0002540) | 1.93019757 |
| 107 | Sleep apnea (HP:0010535) | 1.87793295 |
| 108 | Abnormal EKG (HP:0003115) | 1.85813625 |
| 109 | Pachygyria (HP:0001302) | 1.83119470 |
| 110 | Akinesia (HP:0002304) | 1.82191979 |
| 111 | Spastic tetraparesis (HP:0001285) | 1.80683465 |
| 112 | Hypomagnesemia (HP:0002917) | 1.78925506 |
| 113 | Hypoplasia of the corpus callosum (HP:0002079) | 1.78121586 |
| 114 | Narrow nasal bridge (HP:0000446) | 1.77118761 |
| 115 | Neuroendocrine neoplasm (HP:0100634) | 1.76831516 |
| 116 | Neuronal loss in central nervous system (HP:0002529) | 1.76669256 |
| 117 | Polydipsia (HP:0001959) | 1.74958461 |
| 118 | Abnormal drinking behavior (HP:0030082) | 1.74958461 |
| 119 | Dyskinesia (HP:0100660) | 1.74877124 |
| 120 | Gait ataxia (HP:0002066) | 1.74344629 |
| 121 | Rapidly progressive (HP:0003678) | 1.71909283 |
| 122 | Hypoventilation (HP:0002791) | 1.70391521 |
| 123 | Abnormality of salivation (HP:0100755) | 1.69452372 |
| 124 | Apathy (HP:0000741) | 1.68356190 |
| 125 | Congenital primary aphakia (HP:0007707) | 1.68048324 |
| 126 | Hypercortisolism (HP:0001578) | 1.67101954 |
| 127 | Poor suck (HP:0002033) | 1.67080432 |
| 128 | Psychosis (HP:0000709) | 1.66901334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.29043340 |
| 2 | NTRK3 | 4.12834453 |
| 3 | MAP3K9 | 4.02740412 |
| 4 | MARK1 | 3.29447764 |
| 5 | MAP3K4 | 2.83909608 |
| 6 | MINK1 | 2.68943286 |
| 7 | DAPK2 | 2.43825266 |
| 8 | PAK6 | 2.34415041 |
| 9 | MAP2K7 | 2.24478467 |
| 10 | NTRK2 | 2.22824951 |
| 11 | FRK | 2.08788748 |
| 12 | DAPK1 | 2.03270337 |
| 13 | PRKD3 | 2.01558794 |
| 14 | KSR2 | 1.99926426 |
| 15 | MAP4K2 | 1.79463569 |
| 16 | MAP3K12 | 1.73681650 |
| 17 | KSR1 | 1.69071859 |
| 18 | PRPF4B | 1.68679396 |
| 19 | UHMK1 | 1.64924883 |
| 20 | NTRK1 | 1.64535085 |
| 21 | TYRO3 | 1.63508214 |
| 22 | CAMKK1 | 1.61691038 |
| 23 | CASK | 1.61070013 |
| 24 | MAP2K4 | 1.57680987 |
| 25 | CDK5 | 1.56301594 |
| 26 | ARAF | 1.49778825 |
| 27 | RIPK4 | 1.48796713 |
| 28 | SIK2 | 1.48409491 |
| 29 | ICK | 1.37355550 |
| 30 | GRK5 | 1.37155174 |
| 31 | PINK1 | 1.32149806 |
| 32 | PLK2 | 1.31429650 |
| 33 | STK38 | 1.30263347 |
| 34 | MAPK13 | 1.27504188 |
| 35 | PHKG2 | 1.25984923 |
| 36 | PHKG1 | 1.25984923 |
| 37 | CDK19 | 1.21529418 |
| 38 | PRKCG | 1.18133347 |
| 39 | WNK4 | 1.13851757 |
| 40 | MAP3K6 | 1.12688693 |
| 41 | TNIK | 1.12643166 |
| 42 | LATS2 | 1.10247372 |
| 43 | FES | 1.06486480 |
| 44 | ADRBK2 | 1.05219591 |
| 45 | DDR2 | 1.00216197 |
| 46 | CDK18 | 1.00164828 |
| 47 | MAP3K13 | 0.99974058 |
| 48 | CAMK2A | 0.98652916 |
| 49 | CDK15 | 0.97321394 |
| 50 | CDK14 | 0.93491505 |
| 51 | TRIM28 | 0.92484286 |
| 52 | PNCK | 0.92306036 |
| 53 | FGR | 0.91881662 |
| 54 | RAF1 | 0.89321467 |
| 55 | WNK3 | 0.86911703 |
| 56 | CDK11A | 0.85997006 |
| 57 | MAP3K2 | 0.83881852 |
| 58 | CAMK2B | 0.83051614 |
| 59 | CAMKK2 | 0.82426618 |
| 60 | TAOK1 | 0.82054198 |
| 61 | BMPR1B | 0.81884258 |
| 62 | CAMK1 | 0.81539669 |
| 63 | MARK2 | 0.80953943 |
| 64 | STK11 | 0.77213990 |
| 65 | PKN1 | 0.74882644 |
| 66 | DYRK1A | 0.74785456 |
| 67 | BCR | 0.74464534 |
| 68 | CSNK1G3 | 0.73776954 |
| 69 | STK39 | 0.73477970 |
| 70 | SGK223 | 0.70318363 |
| 71 | SGK494 | 0.70318363 |
| 72 | PRKCH | 0.70182819 |
| 73 | GRK1 | 0.69841664 |
| 74 | PTK2B | 0.66266970 |
| 75 | LIMK1 | 0.66174155 |
| 76 | PAK3 | 0.65938262 |
| 77 | SGK1 | 0.65673875 |
| 78 | SIK3 | 0.65550610 |
| 79 | CSNK1A1L | 0.65544767 |
| 80 | TNK2 | 0.65289882 |
| 81 | ALK | 0.64480345 |
| 82 | CDC42BPA | 0.63542458 |
| 83 | PRKD2 | 0.63031028 |
| 84 | PRKCZ | 0.62649816 |
| 85 | CSNK1G1 | 0.60797817 |
| 86 | RET | 0.60130029 |
| 87 | MAP2K6 | 0.57853767 |
| 88 | CSNK1G2 | 0.56042357 |
| 89 | BMPR2 | 0.55277158 |
| 90 | FGFR2 | 0.55258004 |
| 91 | LMTK2 | 0.54336583 |
| 92 | NEK1 | 0.51902478 |
| 93 | RPS6KA3 | 0.48013656 |
| 94 | ADRBK1 | 0.47511903 |
| 95 | MAPK10 | 0.47049984 |
| 96 | PRKACA | 0.46530954 |
| 97 | OXSR1 | 0.45898211 |
| 98 | ERBB3 | 0.45804815 |
| 99 | SGK2 | 0.45017597 |
| 100 | PDK1 | 0.44287147 |
| 101 | CAMK2D | 0.44041408 |
| 102 | NME1 | 0.43430196 |
| 103 | CAMK2G | 0.43307395 |
| 104 | PDPK1 | 0.43291784 |
| 105 | MAP3K1 | 0.43107817 |
| 106 | PRKCA | 0.42417657 |
| 107 | CAMK4 | 0.42067544 |
| 108 | PRKAA1 | 0.42003170 |
| 109 | SGK3 | 0.41210965 |
| 110 | PRKCE | 0.40835369 |
| 111 | AKT3 | 0.40793346 |
| 112 | MATK | 0.39924148 |
| 113 | INSRR | 0.39619977 |
| 114 | FER | 0.39600727 |
| 115 | CSNK1A1 | 0.38985099 |
| 116 | CCNB1 | 0.38543075 |
| 117 | FYN | 0.38435385 |
| 118 | EPHA3 | 0.37718684 |
| 119 | RIPK1 | 0.36992888 |
| 120 | MAPK12 | 0.36017194 |
| 121 | CSNK1D | 0.35976414 |
| 122 | DYRK2 | 0.35610632 |
| 123 | BRAF | 0.35461625 |
| 124 | DAPK3 | 0.35324798 |
| 125 | BRSK1 | 0.35307454 |
| 126 | PRKG1 | 0.34172182 |
| 127 | CSNK1E | 0.33853923 |
| 128 | MAPKAPK5 | 0.31229115 |
| 129 | PRKCB | 0.28065725 |
| 130 | ERBB2 | 0.27797504 |
| 131 | PRKCQ | 0.25978776 |
| 132 | DYRK1B | 0.25974099 |
| 133 | CAMK1D | 0.25818407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.92781908 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.54959332 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.88582250 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.84218287 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.71790856 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.67741531 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.58885928 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.57012103 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.54572621 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.42165990 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26259753 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.21719475 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.08536597 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.02979206 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.92831766 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.78299366 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.77813238 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.75664834 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.69312565 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.68781244 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68001589 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.65267283 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.61309140 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.60081024 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.54287101 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53291822 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.50369542 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47829603 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.46434092 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34772254 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.34180926 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.30994345 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.30008176 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29821617 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20620739 |
| 36 | Axon guidance_Homo sapiens_hsa04360 | 1.17865111 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13667299 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12361359 |
| 39 | Phototransduction_Homo sapiens_hsa04744 | 1.10468913 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.09630746 |
| 41 | Glioma_Homo sapiens_hsa05214 | 1.09071051 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08983475 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08737947 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08457593 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.08196539 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07289513 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 1.01512522 |
| 48 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.00661115 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96902559 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96498343 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 0.96342434 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95919461 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92809043 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87405640 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82449810 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81593168 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80177942 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80165613 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79573860 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79501451 |
| 61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78089754 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74615165 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74555549 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73690942 |
| 65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72966014 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72563365 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72369620 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70946104 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70852398 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70479459 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70082494 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68045298 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67135076 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66716661 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66234614 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61838897 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59094545 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58755490 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.57557426 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56475180 |
| 81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56203103 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55572257 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54298349 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54120302 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53929561 |
| 86 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53237936 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52938076 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51876752 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.51809159 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51522703 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51267077 |
| 92 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49864374 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47908580 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45380495 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45080549 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.44834815 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44265083 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.43804225 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.41385123 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41167291 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41163394 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40854128 |
| 103 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40828406 |
| 104 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38964276 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38831553 |
| 106 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37789388 |
| 107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36244724 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36105112 |
| 109 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35766551 |
| 110 | Protein export_Homo sapiens_hsa03060 | 0.35586676 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.34539173 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33838334 |
| 113 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.32234493 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31701651 |
| 115 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31659713 |
| 116 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30990099 |
| 117 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30698524 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.29996728 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29362258 |
| 120 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29141561 |
| 121 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.28218536 |
| 122 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27203347 |
| 123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26148698 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26069874 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24606785 |
| 126 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.22943453 |

